Investigating how GLUT1 contributes to heart problems in diabetes
Role of GLUT1 in diabetic cardiomyopathy
This study is looking at how a protein called GLUT1 affects heart health in people with diabetes, especially when diabetes causes heart problems, and it hopes to find new ways to help treat these heart issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11127844 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the GLUT1 glucose transporter in diabetic cardiomyopathy, a condition where diabetes leads to heart failure without other heart diseases. The study will explore how GLUT1 affects heart cells and contributes to heart damage through mechanisms involving oxidative stress and fat toxicity. By examining both human heart samples and mouse models, the researchers aim to uncover the signaling pathways that GLUT1 activates and how inhibiting GLUT1 might offer new treatment options for patients with diabetes-related heart issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Type-1 or Type-2 diabetes who are experiencing heart problems.
Not a fit: Patients without diabetes or those whose heart issues are caused by other conditions unrelated to diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or treat heart failure in diabetic patients.
How similar studies have performed: Previous research has shown promising results in targeting glucose transporters for heart disease treatment, suggesting that this approach could be beneficial.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Drosatos, Konstantinos — University of Cincinnati
- Study coordinator: Drosatos, Konstantinos
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.